Select Medical (NYSE:SEM) Issues FY 2026 Earnings Guidance

Select Medical (NYSE:SEM) updated its FY 2026 earnings guidance on Thursday. The company provided EPS guidance of 1.220-1.320 for the period, compared to the consensus EPS estimate of 1.320. The company issued revenue guidance of $5.6 billion-$5.8 billion, compared to the consensus revenue estimate of $5.6 billion.

Wall Street Analysts Forecast Growth

A number of equities research analysts have weighed in on SEM shares. Mizuho set a $17.00 price objective on Select Medical in a research note on Monday, November 3rd. Wall Street Zen upgraded shares of Select Medical from a “hold” rating to a “buy” rating in a research note on Saturday, November 8th. Weiss Ratings restated a “sell (d+)” rating on shares of Select Medical in a research note on Wednesday, January 21st. Finally, Benchmark reissued a “buy” rating on shares of Select Medical in a report on Monday, October 27th. Four research analysts have rated the stock with a Buy rating, one has given a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $17.80.

Select Medical Stock Performance

NYSE SEM traded down $0.24 on Thursday, hitting $16.08. 1,276,291 shares of the company’s stock were exchanged, compared to its average volume of 701,714. The company has a debt-to-equity ratio of 0.87, a current ratio of 1.09 and a quick ratio of 1.09. The firm’s 50-day moving average price is $15.30 and its two-hundred day moving average price is $14.03. The firm has a market cap of $1.99 billion, a price-to-earnings ratio of 18.70, a P/E/G ratio of 0.57 and a beta of 1.25. Select Medical has a fifty-two week low of $11.65 and a fifty-two week high of $19.40.

Select Medical (NYSE:SEM) last announced its quarterly earnings data on Thursday, February 19th. The health services provider reported $0.16 earnings per share for the quarter, missing analysts’ consensus estimates of $0.23 by ($0.07). The business had revenue of $1.40 billion for the quarter, compared to analyst estimates of $1.36 billion. Select Medical had a return on equity of 7.41% and a net margin of 2.05%.Select Medical has set its FY 2026 guidance at 1.220-1.320 EPS. On average, research analysts expect that Select Medical will post 1.17 EPS for the current year.

Hedge Funds Weigh In On Select Medical

Hedge funds have recently bought and sold shares of the company. Beartown Capital Management LLC purchased a new stake in Select Medical during the fourth quarter worth $2,970,000. State of Tennessee Department of Treasury raised its stake in shares of Select Medical by 33.2% during the 4th quarter. State of Tennessee Department of Treasury now owns 63,307 shares of the health services provider’s stock worth $953,000 after buying an additional 15,787 shares during the last quarter. XTX Topco Ltd boosted its position in shares of Select Medical by 394.2% in the 4th quarter. XTX Topco Ltd now owns 138,229 shares of the health services provider’s stock worth $2,053,000 after buying an additional 110,257 shares in the last quarter. nVerses Capital LLC purchased a new position in Select Medical during the 4th quarter valued at about $163,000. Finally, VARCOV Co. acquired a new position in Select Medical during the fourth quarter worth about $386,000. 89.48% of the stock is owned by hedge funds and other institutional investors.

About Select Medical

Select Medical is a leading provider of specialized healthcare services in the United States, operating through two primary business segments: Hospital Division and Outpatient Rehabilitation Division. The Hospital Division offers long-term acute care (LTAC) hospitals and inpatient rehabilitation facilities (IRFs) that serve patients recovering from complex illnesses, trauma or surgery. The Outpatient Rehabilitation Division delivers physical, occupational and speech therapy services through a network of clinic locations and home-based care programs.

Headquartered in Mechanicsburg, Pennsylvania, Select Medical was founded in 1996 and has grown through strategic partnerships, joint ventures and acquisitions.